Sun Pharma Q1 preview: Higher sales, forex gains could push net profit up 71%
Sun Pharma#39;s US-listed subsidiary Taro Pharmaceutical Industries#39; sales for the June quarter fell 4.2 percent on year to $154.6 million
Latest News from Moneycontrol.com